Literature DB >> 1591731

Amphiregulin messenger RNA is elevated in psoriatic epidermis and gastrointestinal carcinomas.

P W Cook1, M R Pittelkow, W W Keeble, R Graves-Deal, R J Coffey, G D Shipley.   

Abstract

Amphiregulin (AR) is a heparin-regulated, epidermal growth factor-like growth factor capable of stimulating the proliferation of non-tumorigenic cells while inhibiting cell proliferation in some human tumor cell lines in vitro. In the present study, we have investigated AR mRNA expression in normal, hyperproliferative, and neoplastic human epithelium. Our results demonstrate that, compared with the adjacent uninvolved epithelium, AR mRNA expression is markedly elevated in epidermal biopsies derived from three human psoriatic lesions as well as in biopsies derived from five human colon carcinomas and three human stomach carcinomas. Moreover, analysis of a colon carcinoma by in situ hybridization revealed that AR mRNA is localized to the epithelium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591731

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  44 in total

1.  Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway.

Authors:  M Jost; T M Huggett; C Kari; U Rodeck
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 2.  Tyrosine kinases in inflammatory dermatologic disease.

Authors:  Ricardo T Paniagua; David F Fiorentino; Lorinda Chung; William H Robinson
Journal:  J Am Acad Dermatol       Date:  2010-06-26       Impact factor: 11.527

3.  Topography of amphiregulin expression in cultured human keratinocytes: colocalization with the epidermal growth factor receptor and CD44.

Authors:  N Nylander; L T Smith; R A Underwood; M Piepkorn
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

4.  Human antigen R-mediated mRNA stabilization is required for ultraviolet B-induced autoinduction of amphiregulin in keratinocytes.

Authors:  Hironao Nakayama; Shinji Fukuda; Natsuki Matsushita; Hisayo Nishida-Fukuda; Hirofumi Inoue; Yuji Shirakata; Koji Hashimoto; Shigeki Higashiyama
Journal:  J Biol Chem       Date:  2013-02-21       Impact factor: 5.157

5.  Epidermal growth factor receptor activation induces nuclear targeting of cyclooxygenase-2, basolateral release of prostaglandins, and mitogenesis in polarizing colon cancer cells.

Authors:  R J Coffey; C J Hawkey; L Damstrup; R Graves-Deal; V C Daniel; P J Dempsey; R Chinery; S C Kirkland; R N DuBois; T L Jetton; J D Morrow
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

6.  Foveolar hyperplasia following partial gastrectomy results from expansion of surface mucous cell compartment.

Authors:  G S Ray; M W Jackson; J R Goldenring
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

7.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids.

Authors:  Nagaraj S Nagathihalli; Yugandhar Beesetty; Wooin Lee; M Kay Washington; Xi Chen; A Craig Lockhart; Nipun B Merchant
Journal:  Cancer Res       Date:  2014-02-11       Impact factor: 12.701

Review 8.  Trafficking of epidermal growth factor receptor ligands in polarized epithelial cells.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Annu Rev Physiol       Date:  2013-11-08       Impact factor: 19.318

9.  Autocrine extracellular signal-regulated kinase (ERK) activation in normal human keratinocytes: metalloproteinase-mediated release of amphiregulin triggers signaling from ErbB1 to ERK.

Authors:  Sanjay Kansra; Stefan W Stoll; Jessica L Johnson; James T Elder
Journal:  Mol Biol Cell       Date:  2004-07-14       Impact factor: 4.138

10.  TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.

Authors:  Nipun B Merchant; Igor Voskresensky; Christopher M Rogers; Bonnie Lafleur; Peter J Dempsey; Ramona Graves-Deal; Frank Revetta; A Coe Foutch; Mace L Rothenberg; Mary K Washington; Robert J Coffey
Journal:  Clin Cancer Res       Date:  2008-02-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.